Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting about 0. 5–1% of the adult population and manifesting as persistent synovitis, systemic inflammation and production of autoantibodies. Patients affected by RA not only experience chronic disease progression, but are also burdened...

Descripción completa

Detalles Bibliográficos
Autores principales: Giachi, Andrea, Cugno, Massimo, Gualtierotti, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637771/
https://www.ncbi.nlm.nih.gov/pubmed/36352850
http://dx.doi.org/10.3389/fcvm.2022.1012661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637771/
https://www.ncbi.nlm.nih.gov/pubmed/36352850
http://dx.doi.org/10.3389/fcvm.2022.1012661

Ejemplares similares